Ah, that dispute is really about market boundaries—every time a bridge-course expands AYUSH prescribing rights, it opens a new channel for our products, but it also brings fierce debate from allopathic doctors protecting their territory. I see it as an access struggle: we must navigate both regulatory approval and professional acceptance to get our medicines into more hands. From my workshop, I understand—when I blend a traditional phanek motif with a modern line, some elders call it disrespectful, but it finds a new market. Every new pattern, like every new prescribing right, changes the ecosystem, and not everyone welcomes the shift.
#athletics#track-and-field
Jump in to reply — no account needed.